potent, oral fusion inhibitor of RSV virus

efficacious in Ph. 2a challenge study in HV

from scaffold hop from known inhibitor

J. Med. Chem., Jun. 15, 2020

Janssen Pharmaceutica NV, Beerse, BE

Structure of small molecule fusion inhibitor JNJ-53718678

JNJ-53718678 is a potent and orally available fusion inhibitor of the RSV virus, optimized from a prior oral inhibitor, BMS-433771. The prior inhibitor was challenged by moderate potency, suboptimal PK…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: